Publications
Export 22 results:
Filters: Keyword is Phenotype [Clear All Filters]
, “Nav 1.5 mutations linked to dilated cardiomyopathy phenotypes: Is the gating pore current the missing link?”, Channels (Austin), vol. 8, no. 1, pp. 90-4, 2014.
, “Overlap of food addiction and substance use disorders definitions: analysis of animal and human studies.”, Neuropharmacology, vol. 85, pp. 81-90, 2014.
, “A proton leak current through the cardiac sodium channel is linked to mixed arrhythmia and the dilated cardiomyopathy phenotype.”, PLoS One, vol. 7, no. 5, p. e38331, 2012.
, “Gigaxonin mutation analysis in patients with NIFID.”, Neurobiol Aging, vol. 32, no. 8, pp. 1528-9, 2011.
, “Y1767C, a novel SCN5A mutation, induces a persistent Na+ current and potentiates ranolazine inhibition of Nav1.5 channels.”, Am J Physiol Heart Circ Physiol, vol. 300, no. 1, pp. H288-99, 2011.
, “Association with replication between estrogen-related receptor gamma (ESRRgamma) polymorphisms and bone phenotypes in women of European ancestry.”, J Bone Miner Res, vol. 25, no. 4, pp. 901-11, 2010.
, “Chromosome 13q13-q14 locus overlaps mood and psychotic disorders: the relevance for redefining phenotype.”, Eur J Hum Genet, vol. 17, no. 8, pp. 1034-42, 2009.
, “Shared neurocognitive dysfunctions in young offspring at extreme risk for schizophrenia or bipolar disorder in eastern quebec multigenerational families.”, Schizophr Bull, vol. 35, no. 5, pp. 919-30, 2009.
, “Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase.”, J Neurosci, vol. 28, no. 41, pp. 10234-44, 2008.
, “Decomposing the autism phenotype into familial dimensions.”, Am J Med Genet B Neuropsychiatr Genet, vol. 147B, no. 1, pp. 3-9, 2008.
, “Gene-environment interaction and behavioral disorders: a developmental perspective based on endophenotypes.”, Novartis Found Symp, vol. 293, pp. 31-41; discussion 41-7, 68-70, 2008.
, “L-Dopa treatment abolishes the numerical increase in striatal dopaminergic neurons in parkinsonian monkeys.”, J Chem Neuroanat, vol. 35, no. 1, pp. 77-84, 2008.
, “Modest loss of peripheral axons, muscle atrophy and formation of brain inclusions in mice with targeted deletion of gigaxonin exon 1.”, J Neurochem, vol. 107, no. 1, pp. 253-64, 2008.
, “Using disease symptoms to improve detection of linkage under genetic heterogeneity.”, Genet Epidemiol, vol. 32, no. 5, pp. 476-86, 2008.
, “Dopaminergic neurons intrinsic to the striatum.”, J Neurochem, vol. 101, no. 6, pp. 1441-7, 2007.
, “Informative phenotypes for genetic studies of psychiatric disorders.”, Am J Med Genet B Neuropsychiatr Genet, vol. 144B, no. 5, pp. 581-8, 2007.
, “Identifying SNPs predictive of phenotype using random forests.”, Genet Epidemiol, vol. 28, no. 2, pp. 171-82, 2005.
, “Neurochemical characterization of dopaminergic neurons in human striatum.”, Parkinsonism Relat Disord, vol. 11, no. 5, pp. 277-86, 2005.
, “Neuronal fate determinants of adult olfactory bulb neurogenesis.”, Nat Neurosci, vol. 8, no. 7, pp. 865-72, 2005.
, “Loss of function associated with novel mutations of the SCN5A gene in patients with Brugada syndrome.”, Can J Cardiol, vol. 20, no. 4, pp. 425-30, 2004.
, “Electrophysiologic and phenotypic features of an autosomal cone-rod dystrophy caused by a novel CRX mutation.”, Ophthalmology, vol. 109, no. 10, pp. 1862-70, 2002.
, “SCN5A mutation (T1620M) causing Brugada syndrome exhibits different phenotypes when expressed in Xenopus oocytes and mammalian cells.”, FEBS Lett, vol. 467, no. 1, pp. 12-6, 2000.
